Home › Boehringer Ingelheim Selects Medidata Clinical Cloud To Accelerate Innovation In Drug Development
 

Keywords :   


Boehringer Ingelheim Selects Medidata Clinical Cloud To Accelerate Innovation In Drug Development

2015-12-22 01:49:44| drugdiscoveryonline Home Page

Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, recently announced that Boehringer Ingelheim has selected the Medidata Clinical Cloudto accelerate innovation across all of its drug development programs.

Tags: development drug clinical innovation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.04Beiersdorf AG Forges Multi-Year Partnership with Rubedo Life Sciences
24.04Squalene Market Size Positioned to Grow by $64.75 Million by 2027
24.04Outcry led to HMRC's helpline closure U-turn
24.04Perfect Corp.: Q1 2024 Financials
24.04Seattles Climate Pledge Arena Earns TRUE Platinum Certificate for Impressive Waste Diversion Rate
24.04rePurpose Global Broadens Platform with Acquisition of Bluebird Climate
24.04Aveda Develops Care for Curls and Coils
24.04New Door-to-Door Service in East Bay, CA Area Collects Household Recycling Usually Excluded from Curbside Collection
More »